BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25148203)

  • 1. Working memory impairment in cannabis- and opioid-dependent adolescents.
    Vo HT; Schacht R; Mintzer M; Fishman M
    Subst Abus; 2014; 35(4):387-90. PubMed ID: 25148203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Cannabis Dependence Add on to the Neurocognitive Impairment Among Patients With Opioid Dependence? A Cross-Sectional Comparative Study.
    Ghosh A; Basu D; Mattoo SK; Kumar Rana D; Roub F
    Am J Addict; 2020 Mar; 29(2):120-128. PubMed ID: 31951069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls.
    Cousijn J; Vingerhoets WA; Koenders L; de Haan L; van den Brink W; Wiers RW; Goudriaan AE
    Addict Biol; 2014 Mar; 19(2):282-93. PubMed ID: 24589297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders.
    Subramaniam GA; Stitzer ML; Woody G; Fishman MJ; Kolodner K
    Drug Alcohol Depend; 2009 Jan; 99(1-3):141-9. PubMed ID: 18818027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between non-acute adolescent cannabis use and cognition.
    Harvey MA; Sellman JD; Porter RJ; Frampton CM
    Drug Alcohol Rev; 2007 May; 26(3):309-19. PubMed ID: 17454021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cannabis use with opioid outcomes among opioid-dependent youth.
    Hill KP; Bennett HE; Griffin ML; Connery HS; Fitzmaurice GM; Subramaniam G; Woody GE; Weiss RD
    Drug Alcohol Depend; 2013 Sep; 132(1-2):342-5. PubMed ID: 23528523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls.
    Rapeli P; Kivisaari R; Autti T; Kähkönen S; Puuskari V; Jokela O; Kalska H
    BMC Psychiatry; 2006 Feb; 6():9. PubMed ID: 16504127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis withdrawal in patients with and without opioid dependence.
    Chauchard E; Goncharov O; Krupitsky E; Gorelick DA
    Subst Abus; 2014; 35(3):230-4. PubMed ID: 24745656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective and subjective memory ratings in cannabis-dependent adolescents.
    McClure EA; Lydiard JB; Goddard SD; Gray KM
    Am J Addict; 2015 Jan; 24(1):47-52. PubMed ID: 25823635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.
    Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
    J Subst Abuse Treat; 2007 Mar; 32(2):113-9. PubMed ID: 17306720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-Occurrence of Substance-Related and Other Mental Health Disorders Among Adolescent Cannabis Users.
    Zaman T; Malowney M; Knight J; Boyd JW
    J Addict Med; 2015; 9(4):317-21. PubMed ID: 26083957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence.
    Roten A; Baker NL; Gray KM
    Addict Behav; 2015 Jun; 45():119-23. PubMed ID: 25661990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users.
    Nestor L; Roberts G; Garavan H; Hester R
    Neuroimage; 2008 Apr; 40(3):1328-39. PubMed ID: 18296071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Impairment and Tramadol Dependence.
    Bassiony MM; Youssef UM; Hassan MS; Salah El-Deen GM; El-Gohari H; Abdelghani M; Abdalla A; Ibrahim DH
    J Clin Psychopharmacol; 2017 Feb; 37(1):61-66. PubMed ID: 27918316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Self-esteem, coping, perceived social support and substance use in young adults with a cannabis dependence disorder].
    Dorard G; Bungener C; Corcos M; Berthoz S
    Encephale; 2014 Jun; 40(3):255-62. PubMed ID: 23928065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Cannabis Use and Neurocognitive Risk: A Prospective Functional Neuroimaging Study.
    Tervo-Clemmens B; Simmonds D; Calabro FJ; Montez DF; Lekht JA; Day NL; Richardson GA; Luna B
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Aug; 3(8):713-725. PubMed ID: 30033100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence].
    Chauchard E; Septfons A; Chabrol H
    Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.